These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12742933)

  • 1. Folate and risk of cardiovascular disease. Study results were misinterpreted.
    Wald DS; Law M; Morris J; Wald NJ
    BMJ; 2003 May; 326(7397):1035; author reply 1035. PubMed ID: 12742933
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine concentrations lowered following dietary intervention in an aboriginal community.
    Rowley KG; Lee AJ; Yarmirr D; O'Dea K
    Asia Pac J Clin Nutr; 2003; 12(1):92-5. PubMed ID: 12737017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.
    Tobin AM; Hughes R; Hand EB; Leong T; Graham IM; Kirby B
    Clin Exp Dermatol; 2011 Jan; 36(1):19-23. PubMed ID: 20545954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Farhadi D
    N Engl J Med; 1997 Nov; 337(22):1632; author reply 1632-3. PubMed ID: 9411227
    [No Abstract]   [Full Text] [Related]  

  • 7. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
    Miller ER; Juraschek S; Pastor-Barriuso R; Bazzano LA; Appel LJ; Guallar E
    Am J Cardiol; 2010 Aug; 106(4):517-27. PubMed ID: 20691310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine, folic acid, B vitamins and cardiovascular risk.
    Blacher J; Safar ME
    J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum homocysteine in children and adolescents. Relation with family history of cardiovascular disease].
    Casanueva V; Cid X; Cancino M; Borzone L; Cid L
    Rev Med Chil; 2003 Sep; 131(9):997-1002. PubMed ID: 14635586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials.
    Mei W; Rong Y; Jinming L; Yongjun L; Hui Z
    Int J Clin Pract; 2010 Jan; 64(2):208-15. PubMed ID: 19912385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine: an independent risk factor associated with coronary disease and other arterial occlusive diseases in adults.
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(4):37-8. PubMed ID: 8584549
    [No Abstract]   [Full Text] [Related]  

  • 15. [New risk factors for cardiovascular diseases].
    Salamanca-Gómez F
    Gac Med Mex; 1997; 133(5):481-2. PubMed ID: 9504077
    [No Abstract]   [Full Text] [Related]  

  • 16. Homocysteine, B-vitamins and CVD.
    McNulty H; Pentieva K; Hoey L; Ward M
    Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community.
    McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
    Intern Med J; 2005 May; 35(5):289-94. PubMed ID: 15845111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.
    Wald DS; Wald NJ; Morris JK; Law M
    BMJ; 2006 Nov; 333(7578):1114-7. PubMed ID: 17124224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a Portuguese population.
    Araújo F; Lopes M; Gonçalves L; Maciel MJ; Cunha-Ribeiro LM
    Thromb Haemost; 2000 Mar; 83(3):517-8. PubMed ID: 10744169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.